Clinical Trials Directory

Trials / Completed

CompletedNCT02873754

Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)

Mobile Health Intervention to Help Low-Income Smokers Quit Smoking and Increase Physical Activity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This project proposes to evaluate the feasibility, acceptability, and efficacy of a mobile intervention to target smoking-cessation and increase physical activity among low-income persons. The intervention is called Smoking Treatment and Exercise Program for Underserved Populations (STEP UP).

Detailed description

This pilot project proposes to evaluate the feasibility, acceptability, and efficacy of a mobile intervention to target smoking-cessation and physical activity among low-income persons. The intervention, named Smoking Treatment and Exercise Program for Underserved Populations (STEP UP), combines a smartphone-based contingency-management application (app), which provides monetary reinforcement for smoking abstinence and physical activity, 5 weeks of telephone-based cognitive-behavioral therapy (CBT) to prevent relapse, nicotine replacement pharmacotherapy, and text-messaging to support physical-activity goals. Participants are given a smartphone, a compact carbon-monoxide (CO) monitor, with which recency of smoking can by determined, and a Garmin Vivosmart wristband step-tracker. Twice a day at semi-random intervals, participants are prompted by the app to submit a video of themselves blowing into the CO monitor. Monetary reinforcement is then immediately provided contingent upon a below-threshold CO reading. The app also continuously syncs with the Garmin step-tracker, providing supportive messaging and bonus incentives-namely doubled reinforcement for smoking abstinence among participants who meet personalized daily step goals. The expected outcome of the project is to provide information to evaluate the efficacy of an innovative approach in preparation for a subsequent larger clinical trial that builds upon the capabilities of mHealth technology to reduce the prevalence of smoking among low income smokers.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCognitive Behavioral CounselingParticipants will receive five cognitive-behavioral counseling sessions designed to improve rates of smoking cessation, enhance relapse prevention, and increase physical activity.
BEHAVIORALMobile Contingency ManagementParticipants will be asked to provide video recordings of themselves taking carbon monoxide readings in order to confirm smoking abstinence. They will also be asked to wear a fitness tracker to monitor physical activity (i.e., steps walked). Participants are provided monetary reward for videos that suggest smoking abstinence, and for fitness tracker readings that suggest increased physical activity.
DRUGBupropionAll participants who are medically eligible will be prescribed bupropion, which they will start two weeks prior to their quit day. Dosage will be 150 mg/daily for days 1-7 and 300 mg/daily (administered in two daily doses) until the 6-month follow-up.
DRUGTransdermal nicotine patchInitiated at smoking quit date; 7 mg to 21 mg patch depending on amount smoked by participant
DRUGNicotine polacrilexNicotine gum will be initiated at smoking quit date; 4 mg dose administered as needed
DRUGNicotine lozengeNicotine lozenge will be initiated at smoking quit date; 4 mg dose administered as needed

Timeline

Start date
2017-01-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2016-08-19
Last updated
2018-07-13
Results posted
2018-07-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02873754. Inclusion in this directory is not an endorsement.